Regulatory
A securities class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ: ADMA) and certain of its executives, alleging violations of federal securities laws during the Class Period from August 9, 2024 to March…
Impact: Genesis BioPharma Services is the undisclosed related party allegedly involved in the channel stuffing scheme, operating from ADMA's headquarters and sharing ownership ties with the Grossman family. The allegations implicate the entity in the fraud.
Jun 14, 2026 · 294 articles